Integra LifeSciences Holdings Corporation (IART) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Integra LifeSciences Holdings Corporation (IART) Bundle
Designed for accuracy, our (IART) DCF Calculator enables you to evaluate Integra LifeSciences Holdings Corporation’s valuation using real-world financial data and provides complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,517.6 | 1,371.9 | 1,542.4 | 1,557.7 | 1,541.6 | 1,552.3 | 1,563.1 | 1,574.0 | 1,585.0 | 1,596.0 |
| Revenue Growth, % | 0 | -9.6 | 12.43 | 0.98661 | -1.03 | 0.69684 | 0.69684 | 0.69684 | 0.69684 | 0.69684 |
| EBITDA | 231.0 | 267.9 | 366.3 | 391.1 | 274.0 | 314.8 | 317.0 | 319.2 | 321.4 | 323.6 |
| EBITDA, % | 15.22 | 19.53 | 23.75 | 25.11 | 17.77 | 20.28 | 20.28 | 20.28 | 20.28 | 20.28 |
| Depreciation | 114.7 | 119.0 | 123.7 | 121.1 | 123.5 | 124.3 | 125.2 | 126.0 | 126.9 | 127.8 |
| Depreciation, % | 7.56 | 8.67 | 8.02 | 7.78 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 |
| EBIT | 116.3 | 148.9 | 242.7 | 270.0 | 150.5 | 190.5 | 191.8 | 193.1 | 194.5 | 195.8 |
| EBIT, % | 7.67 | 10.86 | 15.73 | 17.33 | 9.76 | 12.27 | 12.27 | 12.27 | 12.27 | 12.27 |
| Total Cash | 198.9 | 470.2 | 513.4 | 456.7 | 309.1 | 403.7 | 406.5 | 409.4 | 412.2 | 415.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 275.3 | 225.5 | 231.8 | 263.5 | 259.3 | 258.8 | 260.6 | 262.4 | 264.2 | 266.0 |
| Account Receivables, % | 18.14 | 16.44 | 15.03 | 16.91 | 16.82 | 16.67 | 16.67 | 16.67 | 16.67 | 16.67 |
| Inventories | 316.1 | 310.1 | 317.4 | 324.6 | 389.6 | 341.9 | 344.3 | 346.7 | 349.1 | 351.5 |
| Inventories, % | 20.83 | 22.61 | 20.58 | 20.84 | 25.27 | 22.02 | 22.02 | 22.02 | 22.02 | 22.02 |
| Accounts Payable | 113.1 | 54.6 | 61.8 | 102.1 | 92.3 | 86.9 | 87.5 | 88.1 | 88.7 | 89.3 |
| Accounts Payable, % | 7.45 | 3.98 | 4.01 | 6.55 | 5.99 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 |
| Capital Expenditure | -134.5 | -63.9 | -48.1 | -47.1 | -66.9 | -74.5 | -75.0 | -75.6 | -76.1 | -76.6 |
| Capital Expenditure, % | -8.87 | -4.66 | -3.12 | -3.02 | -4.34 | -4.8 | -4.8 | -4.8 | -4.8 | -4.8 |
| Tax Rate, % | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 |
| EBITAT | 97.2 | 213.2 | 191.1 | 227.9 | 125.8 | 163.9 | 165.0 | 166.2 | 167.4 | 168.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -400.9 | 265.6 | 260.4 | 303.4 | 111.7 | 256.5 | 211.6 | 213.1 | 214.6 | 216.1 |
| WACC, % | 6.74 | 7.09 | 6.63 | 6.76 | 6.74 | 6.79 | 6.79 | 6.79 | 6.79 | 6.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 921.3 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 224 | |||||||||
| Terminal Value | 6,796 | |||||||||
| Present Terminal Value | 4,893 | |||||||||
| Enterprise Value | 5,814 | |||||||||
| Net Debt | 1,405 | |||||||||
| Equity Value | 4,409 | |||||||||
| Diluted Shares Outstanding, MM | 80 | |||||||||
| Equity Value Per Share | 54.88 |
What You Will Get
- Real IART Financial Data: Pre-filled with Integra LifeSciences' historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Integra LifeSciences' intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Integra LifeSciences Holdings Corporation (IART).
- Tailored Forecast Inputs: Modify highlighted cells for key assumptions such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Enjoy automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation outcomes.
- Designed for All Users: An intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file for Integra LifeSciences Holdings Corporation (IART).
- Step 2: Review the pre-filled financial data and forecasts specific to Integra LifeSciences.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Integra LifeSciences Holdings Corporation (IART)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for (IART).
- Customizable Inputs: Modify yellow-highlighted cells to explore different scenarios for (IART).
- Detailed Insights: Automatically calculates the intrinsic value and Net Present Value specific to (IART).
- Preloaded Data: Access historical and forecasted data for (IART) to ensure accurate analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on (IART).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Integra LifeSciences stock (IART).
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Integra LifeSciences (IART).
- Consultants: Deliver professional valuation insights to clients quickly and accurately regarding Integra LifeSciences (IART).
- Business Owners: Understand how large companies like Integra LifeSciences (IART) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Integra LifeSciences (IART).
What the Template Contains
- Pre-Filled DCF Model: Integra LifeSciences' financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Integra LifeSciences' profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.